🕵️ Therapeuticsmd, Inc. ($TXMD)
SEC insider & ownership activity, last 12 months · CIK 25743 · every row links its SEC filing
Over the last 12 months insiders bought $14K with no open-market selling against it. Tommy Thompson bought $14K in discretionary trades (Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $14K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Tommy Thompson | 1 | $14K | 0 | – | Dec 23, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Clearline Capital LP | 5.5% | 13G | Feb 12, 2025 | filing ↗ | |
| Clearline Capital, LLC | 5.5% | 13G | Feb 12, 2025 | filing ↗ | |
| Marc Majzner | 5.5% | 13G | Feb 12, 2025 | filing ↗ | |
| Baselake Partners, LP | 5.2% | 13G | Apr 6, 2026 | filing ↗ | |
| Baselake Management, LLC | 5.2% | 13G | Apr 6, 2026 | filing ↗ | |
| David Paolella | 5.2% | 13G | Apr 6, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 2, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Auditor change (4.01) | Jan 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 15, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |